These in vitro observations were further validated by an increase in the levels of cleaved PARP and cleaved caspase 3 in CRC cells according to Western blot analysis, indicating increased apoptosis following exposure to the drug combination (Fig 4B). The gene discussed is CASP3; the disease is colorectal carcinoma.